Literature DB >> 8774137

Characterization of a panel of novel anti-p21Waf1/Cip1 monoclonal antibodies and immunochemical analysis of p21Waf1/Cip1 expression in normal human tissues.

S Fredersdorf1, A W Milne, P A Hall, X Lu.   

Abstract

As a universal inhibitor of cyclin-dependent kinases and one of the target genes of the tumor suppresser p53, p21Waf1/Cip1 can act as a tumor suppresser through its ability to control cell cycle progression. To study the function of p21Waf1/Cip1 protein and to investigate its tissue distribution, a panel of anti-p21Waf1/Cip1 monoclonal antibodies was generated. These anti-p21Waf1/Cip1 monoclonal antibodies were initially raised against a GST-p21Waf1/Cip1 fusion protein produced in bacteria. Detailed characterization of the antibodies showed that they can specifically detect p21Waf1/Cip1 by immunoblotting, immunoprecipitation, and immunostaining. The specific induction of p21Waf1/Cip1 expression in response to gamma-radiation in cells containing p53 was also detected by these antibodies. The ability to detect p21Waf1/Cip1 expression in conventionally fixed tissue sections allowed us to investigate the distribution of p21Waf1/Cip1 in 23 different types of normal human tissues, and p21Waf1/Cip1 expression was found in most tissues. A close inverse relationship between p21Waf1/Cip1 expression and proliferation was seen in some tissues, including gastrointestinal tract. However, such association is not universal. In tissues such as lung, kidney, thyroid, pancreatic ducts and acini, and liver, despite the fact that most of the cells are quiescent, expression of p21Waf1/Cip1 was detected only in occasional epithelial cells. All these suggest that the expression of p21Waf1/Cip1 varies among different human tissues. Finally, epitope mapping of the anti-p21Waf1/Cip1 antibodies using a peptide library covering the entire p21Waf1/Cip1 protein sequence indicates that two of the antibodies recognize a region of p21Waf1/Cip1 close to that bound by proliferating cell nuclear antigen. These two monoclonal antibodies will therefore be additionally useful in further understanding the functions of p21Waf1/Cip1 both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774137      PMCID: PMC1861740     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  The complexities of proliferating cell nuclear antigen.

Authors:  D McCormick; P A Hall
Journal:  Histopathology       Date:  1992-12       Impact factor: 5.087

2.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

3.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.

Authors:  W Maltzman; L Czyzyk
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

4.  The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens.

Authors:  D McCormick; C Yu; C Hobbs; P A Hall
Journal:  Histopathology       Date:  1993-06       Impact factor: 5.087

5.  High levels of p53 protein in UV-irradiated normal human skin.

Authors:  P A Hall; P H McKee; H D Menage; R Dover; D P Lane
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

6.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

9.  Discordant regulation of SCL/TAL-1 mRNA and protein during erythroid differentiation.

Authors:  A M Murrell; E O Bockamp; B Göttgens; Y S Chan; M A Cross; C M Heyworth; A R Green
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

10.  Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.

Authors:  C A Midgley; C J Fisher; J Bártek; B Vojtĕsek; D Lane; D M Barnes
Journal:  J Cell Sci       Date:  1992-01       Impact factor: 5.285

View more
  22 in total

1.  Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.

Authors:  H Hayashi; H Miyamoto; T Ito; Y Kameda; N Nakamura; Y Kubota; H Kitamura
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.

Authors:  M S Mateo; A I Saez; M Sanchez-Beato; P Garcia; L Sanchez-Verde; J C Martinez; J L Orradre; M A Piris
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

3.  p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.

Authors:  A N Cheung; D H Shen; U S Khoo; L C Wong; H Y Ngan
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

4.  High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.

Authors:  S Fredersdorf; J Burns; A M Milne; G Packham; L Fallis; C E Gillett; J A Royds; D Peston; P A Hall; A M Hanby; D M Barnes; S Shousha; M J O'Hare; X Lu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  p21WAF1/CTP1 expression and hepatitis virus type.

Authors:  H Wagayama; K Shiraki; T Yamanaka; K Sugimoto; T Ito; K Fujikawa; K Takase; T Nakano
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

6.  Activation of p53 in cervical carcinoma cells by small molecules.

Authors:  S Hietanen; S Lain; E Krausz; C Blattner; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.

Authors:  P Kanavaros; K Stefanaki; K Valassiadou; J Vlachonikolis; M Mavromanolakis; M Vlychou; S Kakolyris; V Gorgoulis; M Tzardi; V Georgoulias
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

8.  p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP.

Authors:  Harsha S Madapura; Daniel Salamon; Klas G Wiman; Sonia Lain; George Klein; Eva Klein; Noémi Nagy
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

9.  The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.

Authors:  Eva Roubalová; Veronika Kvardová; Roman Hrstka; Sárka Borilová; Eva Michalová; Lenka Dubská; Petr Müller; Petr Sova; Borivoj Vojtesek
Journal:  Invest New Drugs       Date:  2009-06-05       Impact factor: 3.850

10.  Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

Authors:  Sonia Lain; Jonathan J Hollick; Johanna Campbell; Oliver D Staples; Maureen Higgins; Mustapha Aoubala; Anna McCarthy; Virginia Appleyard; Karen E Murray; Lee Baker; Alastair Thompson; Joanne Mathers; Stephen J Holland; Michael J R Stark; Georgia Pass; Julie Woods; David P Lane; Nicholas J Westwood
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.